People below 60 years of age with no comorbidities, infected by the Omicron variant of Covid-19, can begin their treatment with paracetamol, Dr Shashank Joshi, member of Maharashtra's Covid task force, said.
In the latest episode of online show Health4All by Heal Foundation, Joshi, an endocrinologist at Lilavati Hospital in Mumbai, said that doctors are likely to prescribe antivirals like Molnupiravir, if someone above the age of 50 has a consistent fever for two days alongside two or three comorbidities.
But "Omicron patients below 60 years with no comorbidities can start symptomatic treatment with paracetamol", he said.
However, paracetamol should not be prescribed to children below the age of 18 years, to pregnant women, or to patients who require hospitalisation, he added.
Earlier, there were reports claiming that paracetamol 500 mg tablets were being given to children along with Covaxin -- the only approved Covid vaccine for teenagers in India.
Vaccine maker Bharat Biotech clarified that Paracetamol or painkillers are not recommended for teenagers after being vaccinated with Covaxin.
Further, Joshi recommended using paracetamol within 72 hours of the onset of symptoms "for patients in the high-risk population group, namely, hypertensives, diabetics, people on immunosuppressed medication, senior citizens, people with other ailments and likewise".
"Whenever we have a new disease which is constantly evolving, new treatment methods are also bound to come up. However, it is up to the doctors to identify the most vulnerable people and prescribe medication accordingly," he added.
--IANS
rvt/sks
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)